Compositions comprising an urolithin compound

US11878964B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11878964-B2
Application numberUS-202117238525-A
CountryUS
Kind codeB2
Filing dateApr 23, 2021
Priority dateAug 28, 2015
Publication dateJan 23, 2024
Grant dateJan 23, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides compositions comprising a source of protein and a urolithin. The invention also provides uses and methods associated with, or making use of the compositions, such as a medicament, dietary supplement, functional food or medical food and in the treatment and/or prophylaxis of a muscle-related pathological condition. The invention also provides kits comprising urolithin and protein.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of improving physical performance, comprising administering to a subject in need thereof an effective amount of a composition comprising a urolithin and a source of protein; wherein the physical performance is walking or running. 2. The method of claim 1 , wherein the subject's performance in the six-minute walk test (MWT) is improved. 3. The method of claim 1 , wherein the subject's time to walk a certain distance (gait speed) is improved. 4. The method of claim 1 , wherein the subject's time to run a certain distance (running speed) is improved. 5. The method of claim 1 , wherein the subject's running economy is improved. 6. The method of claim 1 , wherein the subject's International Physical Activity Questionnaire (IPAQ) score is improved. 7. The method of claim 1 , wherein the subject's number of chair-stands in a certain time is increased. 8. A method of improving muscle function, comprising administering to a subject in need thereof an effective amount of a composition comprising a urolithin and a source of protein; wherein the muscle function is muscle endurance. 9. The method of claim 8 , wherein the subject's muscular contraction strength is increased. 10. The method of claim 8 , wherein the subject's amplitude of muscle contracting is increased. 11. The method of claim 8 , wherein subject's muscle reaction time between stimulation and contraction is shortened. 12. The method of claim 8 , wherein the subject's upper body and/or lower body muscle endurance is improved. 13. The method of claim 12 , wherein the subject's hand grip strength is improved. 14. The method of claim 8 , wherein the subject's skeletal muscle respiratory capacity is increased. 15. The method of claim 14 , wherein the subject's maximal oxygen consumption (VO 2 max ) is increased. 16. The method of claim 8 , wherein the subject's muscle mass is increased. 17. The method of claim 8 , wherein the subject's muscle stem cell regenerative ability is improved. 18. A method of improving physical performance, comprising administering to a subject in need thereof an effective amount of a composition comprising urolithin A and a source of protein. 19. The method of claim 18 , wherein the physical performance is walking or running. 20. A method of improving muscle function, comprising administering to a subject in need thereof an effective amount of a composition comprising urolithin A and a source of protein. 21. The method of claim 20 , wherein the muscle function is muscle endurance.

Assignees

Inventors

Classifications

  • Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title

  • Amino acids, peptides or proteins · CPC title

  • using additives (addition of substantially indigestible substances A23L33/21) · CPC title

  • Drugs for disorders of the nervous system · CPC title

  • Drugs for disorders of the muscular or neuromuscular system · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11878964B2 cover?
The invention provides compositions comprising a source of protein and a urolithin. The invention also provides uses and methods associated with, or making use of the compositions, such as a medicament, dietary supplement, functional food or medical food and in the treatment and/or prophylaxis of a muscle-related pathological condition. The invention also provides kits comprising urolithin and …
Who is the assignee on this patent?
Amazentis Sa
What technology area does this patent fall under?
Primary CPC classification A61K31/37. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).